Functional profiling of OSP-specific and other antibodies during shigella infection

志贺氏菌感染期间 OSP 特异性抗体和其他抗体的功能分析

基本信息

  • 批准号:
    10687224
  • 负责人:
  • 金额:
    $ 76.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-22 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Shigella infection is a leading cause of diarrheal illness in young children in resource-limited settings, and results in tens of thousands of deaths each year. Protection against shigellosis is associated with antibodies targeting O-specific polysaccharide (OSP), but immune responses against other antigens have also been noted to correlate with protection. Functional attributes of anti-shigella antibodies have also been noted to correlate with protection, including complement activation and ability to induce host cell phagocytic activity. Despite this, a shigella OSP-conjugate vaccine failed to protect young children in a field trial, despite providing protection in older children and adults. We propose that such issues may reflect differences not only in antibody magnitude (titer) following vaccination, but also differences in antibody functional effector attributes, including Fc interactions with the innate immune system. Such differences have been noted to correlate with protection against a range of infectious pathogens. To address this, we propose to define antibody functional and biophysical attributes associated with protection against shigella infection, including in young children, using a household contact study design approach in an informal settlement area in Dhaka, Bangladesh. We propose to complement this analysis with data from North American vaccine and Controlled Human Infection Models (CHIMs) and related studies. We anticipate that we will identify a profile of antibody attributes that correlates with protection against shigellosis, that this knowledge will critically guide vaccine development and evaluation efforts, and that this knowledge will focus future mechanistic studies.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edward T. Ryan其他文献

Systems approach to define humoral correlates of immunity to emShigella/em
系统方法来定义对志贺氏菌的免疫体液相关性
  • DOI:
    10.1016/j.celrep.2022.111216
  • 发表时间:
    2022-08-16
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Biana Bernshtein;Esther Ndungo;Deniz Cizmeci;Peng Xu;Pavol Kováč;Meagan Kelly;Dilara Islam;Edward T. Ryan;Karen L. Kotloff;Marcela F. Pasetti;Galit Alter
  • 通讯作者:
    Galit Alter
Case 38-2011
案例38-2011
  • DOI:
    10.1056/nejmcpc1011322
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Edward T. Ryan;Carmel G. Cronin;John A. Branda
  • 通讯作者:
    John A. Branda
Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice
使用霍乱弧菌减毒疫苗株进行口服免疫,该疫苗株表达与霍乱毒素 B 亚基融合的富含丝氨酸的溶组织内阿米巴蛋白的十二肽重复序列,可诱导全身和粘膜抗阿米巴和抗 V。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Edward T. Ryan;J. Butterton;Tonghai Zhang;Meghan A. Baker;Samuel L. Stanley;Stephen B. Calderwood
  • 通讯作者:
    Stephen B. Calderwood
Comparison of O-specific polysaccharide responses in patients following infection with emVibrio cholerae/em O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh
孟加拉国感染 em 霍乱弧菌/O139 后患者与接种二价(O1/O139)口服灭活霍乱疫苗后患者 O 特异性多糖反应的比较
  • DOI:
    10.1128/msphere.00255-23
  • 发表时间:
    2023-09-28
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    M. Hasanul Kaisar;Meagan Kelly;Mohammad Kamruzzaman;Taufiqur R. Bhuiyan;Fahima Chowdhury;Ashraful Islam Khan;Regina C. LaRocque;Stephen B. Calderwood;Jason B. Harris;Richelle C. Charles;Alžbeta Čížová;Jana Mečárová;Jana Korcová;Slavomír Bystrický;Pavol Kováč;Peng Xu;Firdausi Qadri;Edward T. Ryan;David W. Pascual
  • 通讯作者:
    David W. Pascual
Antibiotic resistance and serotype distribution of emShigella/em strains in Bangladesh over the period of 2014–2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases
2014-2022 年期间孟加拉国志贺氏菌属菌株的抗生素耐药性和血清型分布:全国医院霍乱及其他腹泻病监测的证据
  • DOI:
    10.1128/spectrum.00739-24
  • 发表时间:
    2024-10-30
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Mokibul Hassan Afrad;Md. Taufiqul Islam;Yasmin Ara Begum;Md. Saifullah;Faisal Ahmmed;Zahid Hasan Khan;Zakir Hossain Habib;Ahmed Nawsher Alam;Tahmina Shirin;Taufiqur Rahman Bhuiyan;Edward T. Ryan;Ashraful Islam Khan;Firdausi Qadri
  • 通讯作者:
    Firdausi Qadri

Edward T. Ryan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edward T. Ryan', 18)}}的其他基金

Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation
志贺氏菌结合疫苗 (SCV4) 的开发、表征和临床前评估
  • 批准号:
    10704325
  • 财政年份:
    2023
  • 资助金额:
    $ 76.19万
  • 项目类别:
Functional profiling of OSP-specific and other antibodies during shigella infection
志贺氏菌感染期间 OSP 特异性抗体和其他抗体的功能分析
  • 批准号:
    10468290
  • 财政年份:
    2020
  • 资助金额:
    $ 76.19万
  • 项目类别:
Functional profiling of OSP-specific and other antibodies during shigella infection
志贺氏菌感染期间 OSP 特异性抗体和其他抗体的功能分析
  • 批准号:
    10267700
  • 财政年份:
    2020
  • 资助金额:
    $ 76.19万
  • 项目类别:
Functional profiling of OSP-specific and other antibodies during shigella infection
志贺氏菌感染期间 OSP 特异性抗体和其他抗体的功能分析
  • 批准号:
    10087677
  • 财政年份:
    2020
  • 资助金额:
    $ 76.19万
  • 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
  • 批准号:
    8836484
  • 财政年份:
    2014
  • 资助金额:
    $ 76.19万
  • 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
  • 批准号:
    10598007
  • 财政年份:
    2013
  • 资助金额:
    $ 76.19万
  • 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
  • 批准号:
    8705757
  • 财政年份:
    2013
  • 资助金额:
    $ 76.19万
  • 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
  • 批准号:
    10372233
  • 财政年份:
    2013
  • 资助金额:
    $ 76.19万
  • 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
  • 批准号:
    10263266
  • 财政年份:
    2013
  • 资助金额:
    $ 76.19万
  • 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
  • 批准号:
    10116755
  • 财政年份:
    2013
  • 资助金额:
    $ 76.19万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.19万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了